ELIZABETH BLANCHARD HILLS: Open Payments
NPI 1013483031 · KANSAS CITY, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,644 in 36 payments from 12 companies in 2025. Trend: 2023 $700 · 2024 $840 · 2025 $1,644
Food & beverage: $837Travel & lodging: $808
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 13 | $1,093 |
| Neurocrine BioSciences, Inc. | 3 | $130 |
| Otsuka America Pharmaceutical, Inc. | 3 | $70 |
| Teva Pharmaceuticals USA, Inc. | 3 | $68 |
| Axsome Therapeutics, Inc. | 3 | $60 |
| E.R. Squibb & Sons, L.L.C. | 3 | $51 |
| ABBVIE INC. | 2 | $42 |
| Noven Therapeutics, LLC | 2 | $34 |
| Biogen, Inc. | 1 | $28 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $25 |
Products named: SPRAVATO, INGREZZA, AUSTEDO XR, Auvelity, COBENFY, ABILIFY ASIMTUFII, REXULTI, VRAYLAR.
Industry payments across MO — which companies pay providers there.
